Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.65 |
| ▸ | BLM | P54132 | 2/20 | 0.65 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.65 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.65 |
| ▸ | DRD1 | P21728 | 1/20 | 0.65 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.65 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.65 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.65 |
| ▸ | DRD3 | P35462 | 1/20 | 0.65 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.65 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.65 |
| ▸ | EYA2 | O00167 | 1/20 | 0.60 |
| ▸ | APP | P05067 | 1/20 | 0.60 |
| ▸ | ACE | P12821 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16317687 | 0.97 | TSHR (0.70) | TSHRTDP1ALOX15BLMPMP22 | |
| SCHEMBL10950013 | 0.97 | TSHR (0.62) | TSHRTDP1ALOX15BLMPMP22 | |
| SCHEMBL30788728 | 0.97 | TSHR (0.62) | TSHRTDP1ALOX15BLMPMP22 | |
| SCHEMBL19018808 | 0.97 | TSHR (0.70) | TSHRTDP1ALOX15BLMPMP22 | |
| Hydrochloric Acid SCHEMBL7108936 | 0.97 | TSHR (0.62) | TSHRTDP1ALOX15BLMPMP22 | |
| Potassium SCHEMBL30788727 | 0.97 | TSHR (0.62) | TSHRTDP1ALOX15BLMPMP22 | |
| SCHEMBL20392792 | 0.95 | TDP1 (0.75) | TSHRTDP1ALOX15BLMPMP22 | |
| SCHEMBL29223018 | 0.95 | TDP1 (0.75) | TSHRTDP1ALOX15BLMPMP22 | |
| SCHEMBL22779173 | 0.95 | TDP1 (0.67) | TSHRTDP1ALOX15BLMPMP22 | |
| SCHEMBL6254463 | 0.94 | TDP1 (0.68) | TSHRTDP1ALOX15BLMPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 850 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250281440-A1 | METHOD TO IMPROVE GROWTH PERFORMANCE, LIVABILITY, CARCASS CHARACTERISTICS AND/OR MILK QUALITY IN SWINE | NUTRIQUEST, LLC | 2025-09-11 | — | — | US | claimed |
| CN-117820177-A | Additive composition for preparing 2-hydroxy-4- (methylthio) butyronitrile and application thereof in preparation of methionine | 万华化学集团股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-117682680-A | Storage-stable methyl glycine-N, N-diacetic acid tri-alkali metal salt composition, preparation method and application thereof | 万华化学集团股份有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-114507303-A | External electron donor for olefin polymerization, catalyst system and olefin polymerization method | 中国石油化工股份有限公司 | 2022-05-17 | — | — | CN | claimed |
| CN-114478870-A | Catalyst system for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-107987189-B | Catalyst component for olefin polymerization and preparation method and application thereof | 中国石油化工股份有限公司 | 2021-05-11 | — | — | CN | claimed |
| CN-110869394-A | Engineered antibody compounds and conjugates thereof | 伊莱利利公司 | 2020-03-06 | — | — | CN | claimed |
| CN-104418825-B | The method of purification of Lipstatin | 北大方正集团有限公司 | 2016-12-28 | — | — | CN | claimed |
| US-20140316004-A1 | TREATMENT OF POULTRY FOR REDUCING THE FEED CONVERSION RATE OR FOR REDUCING THE INCIDENCE OF ASCITES | TAMINCO N.V. (BE) | 2014-10-23 | — | — | US | claimed |
| US-8486370-B2 | Heterocyclic ligands for integrin imaging and therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-07-16 | — | — | US | claimed |
| US-6566334-B1 | For therapy of bacterial infection | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2003-05-20 | — | — | US | claimed |
| EP-1309612-A2 | PSEUDO-METALLOPROTEINS, CORRESPONDING PREPARATION AND USE AS BIOSENSORS | UNIVERSITA' DEGLI STUDI DI NAPOLI (IT) | 2003-05-14 | — | — | EP | claimed |
| US-6489297-B1 | ANTI-NEOPLASTIC ACTIVITY OF NOVEL VIP PEPTIDE ANALOGS USING SELECTED CONSTRAINED AMINO ACIDS SUCH AS DIETHYLGLYCINE, 1-AMINOCYCLOPENTANE CARBOXYLIC ACID AND DI-N-PROPYLGLYCINE | DABUR RESEARCH FOUNDATION (IN) | 2002-12-03 | — | — | US | claimed |
| WO-2002012278-A2 | PSEUDO-METALLOPROTEINS, CORRESPONDING PREPARATION AND USE AS BIOSENSORS | UNIVERSITA' DEGLI STUDI DI NAPOLI 'FEDERICO II' (IT) | 2002-02-14 | — | — | WO | claimed |
| CN-1077439-C | Labeled chemotactic peptides for imaging of sites of infection or inflammation lesions | GEN HOSPITAL CORP (US) | 2002-01-09 | — | — | CN | claimed |
| EP-0732944-A4 | LABELED CHEMOTACTIC PEPTIDES TO IMAGE FOCAL SITES OF INFECTION OR INFLAMMATION | GEN HOSPITAL CORP (US) | 2000-06-07 | — | — | EP | claimed |
| US-5792444-A | ADMINISTERING LABELED CHEMOTACTIC PEPTIDE WHICH ACCUMULATES AT SITE OF INFECTION OR INFLAMMATION | THE GENERAL HOSPITAL CORPORATION (US) | 1998-08-11 | — | — | US | claimed |
| CN-1141002-A | Labeled chemotactic peptides for imaging of sites of infection or inflammation lesions | GEN HOSPITAL CORP (US) | 1997-01-22 | — | — | CN | claimed |
| EP-0732944-A1 | LABELED CHEMOTACTIC PEPTIDES TO IMAGE FOCAL SITES OF INFECTION OR INFLAMMATION | THE GENERAL HOSPITAL CORPORATION (US) | 1996-09-25 | — | — | EP | claimed |
| WO-1995011045-A1 | LABELED CHEMOTACTIC PEPTIDES TO IMAGE FOCAL SITES OF INFECTION OR INFLAMMATION | THE GENERAL HOSPITAL CORPORATION (US) | 1995-04-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140316004-A1 | TREATMENT OF POULTRY FOR REDUCING THE FEED CONVERSION RATE OR FOR REDUCING THE INCIDENCE OF ASCITES | OAT, AADAT, HDGF | TSHR 1678/4885TDP1 4421/4885ALOX15 1353/4885 |
| US-20250281440-A1 | METHOD TO IMPROVE GROWTH PERFORMANCE, LIVABILITY, CARCASS CHARACTERISTICS AND/OR MILK QUALITY IN SWINE | PIGS, GLO1, IGFBP6 | TSHR 2564/4885TDP1 1156/4885ALOX15 1303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.